新股暗盘｜卓正医疗暗盘收涨57.01% 一手赚逾1700港元

Core Viewpoint - China’s private healthcare service provider, Zhuozheng Medical (2677.HK), is set to list in Hong Kong on February 6, with its dark pool trading showing a significant increase of 57.01% from the IPO price, indicating strong market interest and potential for growth [1][2]. Group 1: Company Overview - Zhuozheng Medical positions itself as the "Costco" of health service consumption, focusing on high-quality, cost-effective service experiences for its members [1]. - The company has developed a health service ecosystem centered around "super users," emphasizing high-frequency health service consumption through a multi-specialty family model [1]. - Zhuozheng Medical aims to break the traditional low-frequency consumption model of single-specialty medical institutions, achieving high repurchase rates and user loyalty [1]. Group 2: Market Trends - The "self-care economy" is reshaping the market, with consumers increasingly prioritizing emotional satisfaction and quality experiences, leading to sustained growth in health and wellness investments [1]. - The health service sector is entering a golden development period, driven by rising consumer demand for quality health services [1]. Group 3: Investment Details - Zhuozheng Medical's IPO has attracted cornerstone investors including Health Vision, Kingmed Diagnostics, Minglue Technology, and Galaxy Dynasty, owned by He Xiaopeng, co-founder of Xiaopeng Motors [2]. - The stock closed at 94.05 HKD in dark pool trading, significantly above the IPO price of 59.9 HKD, reflecting strong investor confidence [2].